Current Issue

Category: 2023

Effects of combined metformin and cabergoline versus metformin alone on ovarian and hormonal activities in Iraqi patients with PCOS and hyperprolactinemia: a randomized clinical trial

Hamad Inas Naser 1 et al.
2023
Issue 11
pp 1615 - 1621
DOI: 10.25122/jml-2023-0317

Polycystic ovary syndrome (PCOS) is one of the most prevalent metabolic diseases during female reproductive life, often associated with insulin resistance and hyperprolactinemia. The efficacy of metformin and cabergoline for...

View Article Download PDF

SCImago Journal & Country Rank

Issues

Special Issues